Immuron IMRN
NASDAQ IMRN
$1.24 +0.02 (+1.64%)
At close: Sep 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Amortization of Deferred Charges (2020 - 2021)

Immuron (IMRN) posted Amortization of Deferred Charges of $10596.7 for Q2 2021, down 25.26% on a QoQ basis from $14177.4 in Q2 2020, and down 25.26% year-over-year from $14177.4 in Q2 2020.

Analysis

Immuron (IMRN) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends

Immuron has reported Amortization of Deferred Charges for 2 years, with the latest figure at $10596.7 in Q2 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 Immuron 7.14 Mn -1.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 10,596.73
Jun 30, 2020 14,177.40
API Access

Immuron Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IMRN&period=max&api_key=YOUR_API_KEY